Assenagon Asset Management’s Sangamo Therapeutics SGMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-293,949
| Closed | -$193K | – | 1204 |
|
|
2025
Q1 | $193K | Buy |
+293,949
| New | +$193K | ﹤0.01% | 1097 |
|
|
2024
Q1 | – | Sell |
-1,033,322
| Closed | -$561K | – | 1425 |
|
|
2023
Q4 | $561K | Buy |
1,033,322
+129,811
| +14% | +$70.5K | ﹤0.01% | 1190 |
|
|
2023
Q3 | $542K | Sell |
903,511
-36
| -0% | -$22 | ﹤0.01% | 1141 |
|
|
2023
Q2 | $1.17M | Hold |
903,547
| – | – | ﹤0.01% | 906 |
|
|
2023
Q1 | $1.59M | Buy |
903,547
+39,107
| +5% | +$68.8K | 0.01% | 896 |
|
|
2022
Q4 | $2.71M | Sell |
864,440
-8,544
| -1% | -$26.8K | 0.01% | 682 |
|
|
2022
Q3 | $4.28M | Sell |
872,984
-39
| -0% | -$191 | 0.02% | 502 |
|
|
2022
Q2 | $3.61M | Hold |
873,023
| – | – | 0.01% | 619 |
|
|
2022
Q1 | $5.07M | Buy |
873,023
+860,547
| +6,898% | +$5M | 0.01% | 500 |
|
|
2021
Q4 | $94K | Buy |
+12,476
| New | +$94K | ﹤0.01% | 1352 |
|
|
2020
Q4 | – | Sell |
-332,611
| Closed | -$3.14M | – | 1186 |
|
|
2020
Q3 | $3.14M | Buy |
+332,611
| New | +$3.14M | 0.02% | 443 |
|